Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Transform your credit card points into charitable contributions. Discover how to donate your rewards and support meaningful causes in your community.
17,796 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
From classroom grades to a billion-dollar chicken brand, Raising Cane’s growth highlights the power—and perils—of a s...
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Tim Cook's travels to China are more than diplomacy. This piece outlines how what cook's trip china could mean for Ap...
Citi boosts its Intel price target to $130, arguing a new CPU TAM framework driven by agentic AI workloads positions ...
A major wealth manager trimmed a climate-focused ETF by $10.6 million in Q1 2026. This article breaks down what that ...
NuScale Power just reported earnings, and the market pushed the stock lower. This article explains why patient invest...
A 70/30 portfolio looks conservative on paper, but the 2022 stress test exposes a $187,000 shortfall on a $2.1 millio...
Ethereum retreats toward the $2,100 level as macro factors weigh on the market, setting up a test of demand for one o...
A 64-year-old executive faces a year of severance after a sudden layoff and chooses to claim Social Security at 64. T...
Truth Social’s spot Bitcoin ETF has withdrawn its S-1 filing, signaling tougher market conditions for plain-vanilla c...
Nvidia’s quarterly print arrives amid an AI demand cycle that remains uneven. Analysts say nvidia earnings don’t matt...